Introduction {#s01}
============

γδ T cells constitute one of three conserved lymphocyte populations rearranging clonal antigen receptors. Compared with αβ T cells and B cells, γδ T cells account for a smaller fraction of lymphocytes in blood and secondary lymphoid organs, but are more abundant in mucosal tissues and skin ([@bib8]). There, IL-17--producing γδ T cells (Tγδ17 cells) are thought to be the main source of the pro-inflammatory cytokines IL-17A and IL-17F, which protect the body's surfaces from fungal ([@bib59]; [@bib10]) and bacterial infections ([@bib9]; [@bib71]; [@bib45]) and play a role in the regulation of adipose tissue homeostasis and thermogenesis ([@bib33]). But Tγδ17 cells are also involved in the pathogenesis of inflammatory and autoimmune diseases ([@bib52], [@bib53]), in particular experimental autoimmune encephalomyelitis ([@bib55]), spondyloarthritis ([@bib63]) and psoriasis ([@bib5]; [@bib50]; [@bib60]). In mice, fetal Vγ6^+^ and a fraction of early Vγ4^+^ cells already differentiate in the prenatal thymus into Tγδ17 effector cells and then egress to populate a wide range of organs ([@bib27]; [@bib18], [@bib19]; [@bib64]). However, recent findings challenged the view that all Tγδ17 effector cells are exclusively derived from fetal thymus by showing that under certain circumstances, Tγδ17 cells may also develop in adult mice, e.g., by recognition of cognate antigen ([@bib81]) or by TCR stimulation in the presence of IL-1β and IL-23 ([@bib48]; [@bib51]; [@bib80]).

In peripheral tissues, the large majority of Tγδ17 cells display TCRs with rearrangements using Vγ4 or Vγ6 segments ([@bib58]). Many Vγ4^+^ and Vγ6^+^ Tγδ17 cells show canonical semi-invariant TCR rearrangements without additions of nontemplated N nucleotides ([@bib29]; [@bib78]), supporting the hypothesis that their capacity to produce IL-17 cytokines is prewired in a subset of fetal T cell precursors before and independent of antigen-specific TCR selection ([@bib19]; [@bib58]). In some tissues, particularly in the dermis, virtually all γδ T cells share a Tγδ17 phenotype and are likely tissue-resident ([@bib17]; [@bib39]; [@bib71]; [@bib28]). Furthermore, it is still unclear to what extent the task of local IL-17 cytokine production is distributed between Tγδ17 cells, Th17 cells, and IL-17--producing innate lymphoid cells (ILC3s) and whether these sources may actually be redundant ([@bib11]; [@bib35]; [@bib72]). To separate the specific physiological roles of Tγδ17 and other IL-17--producing cells, several studies used monoclonal antibodies that may lead to blocking and internalization of the γδ TCR, sometimes with significant biological effects ([@bib68]; [@bib56]; [@bib4]). However, we have previously shown that treatment with anti-TCR antibodies including the clones GL3 and UC7-13D5 does not deplete γδ T cells in vivo, but rather leads to TCR internalization and thereby generates "invisible" γδ T cells ([@bib32]). Additionally, TCR delta chain knock-out mice (*Tcrd*^−/−^) are a very useful loss-of-function system for studying T cell development and γδ T cell function ([@bib25]; [@bib66]; [@bib79]). However, the immune phenotype of *Tcrd*^−/−^ mice is surprisingly mild ([@bib46]; [@bib61]), possibly because plastic αβ T cells can somehow occupy the niches of absent γδ T cells and might partially take over their functions ([@bib26]).

Here we investigated the regenerative capacity and function of Tγδ17 cells in vivo in immunocompetent mice. To this end, we generated a novel genetic knock-in model for diphtheria toxin (DTx)--mediated conditional γδ T cell depletion, and additionally used an inducible γδ T cell--specific Cre system to track the relative persistence of γδ T cell subsets in vivo. These genetic systems allowed us to revisit and compare the regenerative capacity between adult Tγδ17 cells and other γδ T cell subsets and to explore the function of γδ T cells in vivo.

Results {#s02}
=======

To investigate the function of γδ T cells by conditional depletion in immunocompetent mice with normal γδ T cell compartments, we generated *Tcrd*-GDL mice expressing enhanced GFP (eGFP), human DTx receptor (DTR), and luciferase under the control of an IRES in the 3′UTR of the *Tcrd* constant gene (Fig. S1). The γδ T cell--specific cytoplasmic eGFP expression served to directly visualize γδ T cell morphology and their tissue-screening activity in skin and intestinal mucosa in vivo ([Fig. 1, A and B](#fig1){ref-type="fig"}; and Videos 1 and 2). Upon injection of luciferin substrate, luciferase activity indicated the distribution of γδ T cells across tissues ([Fig. 1 C](#fig1){ref-type="fig"}). Notably, γδ T cell--specific DTR expression enabled us to efficiently and truly deplete γδ T cells in homozygous *Tcrd*-GDL mice by a single DTx treatment without compromising peripheral CD4^+^ and CD8^+^ αβ T cells ([Fig. 1 D](#fig1){ref-type="fig"} and Fig. S2, A--C). Nevertheless, the DTR (along with eGFP and luciferase) is expressed in maturing thymocytes via germline promotors of the *Tcrd* constant gene before the *Tcrd* locus is excised during *Tcra* rearrangement at the CD4/CD8 double-positive stage (Fig. S2 D; [@bib6]; [@bib57]), and thus, thymic cellularity was transiently compromised after DTx treatment (Fig. S2 D). After conditional depletion, γδ T cells reappeared quickly already within 2 wk (Fig. 2 A), suggesting that the induced γδ T cell deficiency was partially reversible. However, distinct γδ T cell subsets showed divergent regeneration kinetics. CD27^+^CD44^low^ γδ T cells with an IFN-γ--producing phenotype fully regained predeletion levels in peripheral LNs (pLN) and spleen after 7 wk, while Tγδ17 cells, as defined by their CD27^--^CD44^high^ phenotype, were poorly reconstituted ([Fig. 2 B](#fig2){ref-type="fig"} and Fig. S3 A). This finding is consistent with our previous data showing that Tγδ17 subsets do not develop de novo after bone marrow transplantation or after induction of T cell development in adult *Rag1*-deficient mice ([@bib19]). Along this line, pLN Vγ1^+^ and intestinal Vγ7^+^ cells recovered efficiently (Fig. S3 B), but Vγ6^+^ and Vγ4^+^ cells did not (Fig. S3 C). Nevertheless, the rare Tγδ17 cells that were present at 8--9 wk after DTx treatment maintained a TCR repertoire that was similar to the TCR repertoire before depletion ([Fig. 2 C](#fig2){ref-type="fig"}), suggesting that these cells presumably originated from expansion of a few cells that survived the DTx treatment.

![**eGFP, luciferase, and DTx receptor are functionally expressed by γδ T cells. (A)** Two-photon in vivo imaging of *Tcrd*-GDL mouse ear skin and small intestine. Green, γδ T cell eGFP; blue, second harmonics (ear skin) or Hoechst 33342 nuclear staining (small intestine). Bars: 50 µm (ear skin); 15 µm (small intestine; see also Videos 1 and 2). **(B)** eGFP expression by peripheral lymph node γδ T cells (green, gated as CD45^+^Tcrβ^--^CD3^+^TCRγδ^+^), αβ T cells (blue, gated as CD45^+^Tcrβ^+^CD3^+^), and B cells (red, gated as CD45^+^Tcrβ^--^CD3^--^CD19^+^) of a *Tcrd*-GDL mouse and CD45^+^ cells of a C57BL/6-NCrl mouse (WT, filled gray line). Shown is one representative histogram of two experiments with each *n* = 2--3 mice per group. **(C)** Bioluminescence by functional luciferase expression was detected by IVIS in at least two independent experiments with *n* = 1--2 mice each. C57BL/6-NCrl WT and *Tcrd*-GDL were sacrificed 10 min after injection of [d]{.smallcaps}-luciferin and the indicated organs were displayed for imaging. Color bar corresponds to signal intensities measured as photons. c, colon; k, kidney; li, liver; lu, lung; pl: peripheral lymph node; si, small intestine; sp, spleen; st, stomach; t, thymus. **(D)** Depletion of γδ T cells using DTx was analyzed by flow cytometry. Representative contour plot of pLN T cells (CD3^+^ cells) of *Tcrd*-GDL mice treated with PBS (ctrl.) or DTx (top). Cell counts of indicated cell populations in pLNs of DTx- (white bars) and PBS- (black bars) injected *Tcrd*-GDL and C57BL/6-NCrl WT mice (bottom). Bar graphs show pooled data from four independent experiments with each *n* = 1--3 mice per group, Kruskal Wallis test with Dunn\'s Multiple Comparison post-tests. \*, P \< 0.05; ns, not significant.](JEM_20181439_Fig1){#fig1}

![**Depletion of Tγδ17 cells does not change their repertoire. (A and B)** Flow cytometric analysis of indicated cell populations 1 d (d1), 2 wk (2w), and 7 wk (7w) after depletion of γδ T cells in *Tcrd*-GDL littermate mice. Shown are pooled data from three independent experiments with each *n* = 2 - 5 mice per group, Student's *t* test. **(A)** Bar graph shows frequencies of γδ T cells (Tcrβ^--^GFP^+^) among T cells (A.dead^--^CD3^+^) in peripheral lymph nodes, mean ± SD. **(B)** Scatter plots show frequencies of indicated γδ T cell populations among all γδ T cells in peripheral lymph nodes, one dot represents one mouse, mean. **(C)** T cell receptor repertoire analysis of γδ T cell nondepleted (ctrl., left) and depleted *Tcrd*-GDL mice 8--9 wk after depletion (right). Sorted CD44^hi^Ly6C^--^Vγ4^+^ peripheral lymph node cells were pooled from 7 - 8 mice each and facilitated to Illumina NGS. Amplicons were generated by multiplex PCR. Proportions of Vγ4 (top) and Vδ5 (bottom) top 20 and top 5 amino acid (AA) clonotypes among complete Vγ4 and Vδ5 repertoires. Amino acid sequences of the top 5 clonotypes. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant.](JEM_20181439_Fig2){#fig2}

In skin, overall recovery of γδ T cells was very poor ([Fig. 3 A](#fig3){ref-type="fig"}). Nevertheless, via screening epidermal sheets, we could identify some Vγ5^+^ dendritic epidermal T cells (DETCs) that sporadically reappeared in isolated clonal patches ([Fig. 3, B and C](#fig3){ref-type="fig"}; and Video 3). Likely, a few individual DETCs resisted the DTx treatment, similar to the survival of some Tγδ17 cells described above. Of note, empty niches of conditionally depleted DETCs could not be invaded and repopulated by unconventional αβ T cells (Fig. S4). This is in contrast to the situation in constitutively γδ T cell--deficient *Tcrd*^−/−^ mice, in which fetal-derived DETCs using αβ TCR populate the epidermis ([@bib26]). Interestingly, DTx treatment of heterozygous *Tcrd* ^GDL/WT^ mice induced a scattered "cow pattern" depletion of DETCs ([Fig. 3 D](#fig3){ref-type="fig"}). Together, these findings are consistent with the hypothesis that individual fetal DETC precursors colonize the epidermis early in life to form clonal lateral colonies ([@bib54]).

![**Patchy depletion and recovery of ear skin γδ T cells. (A)** Frequencies of γδTCR^hi^ epidermal (left) and γδTCR^lo^ dermal (right) γδ T cells in nondepleted (ctrl.) and 7-wk-ago--depleted (7w) *Tcrd*-GDL mice. Pooled data from two independent experiments, one dot represents one mouse, mean. **(B)** Longitudinal in vivo two-photon imaging of *Tcrd*-GDL ear skin. Images were acquired from the same mouse at indicated time points after γδ T cell depletion. As reference, a mouse was injected with PBS (ctrl.). Green: γδ T cell eGFP by *Tcrd*-GDL mice, shown are representative images of two independent experiments. Bars, 50 µm (see Video 3). **(C)** Epidermal sheets of DTx- and PBS (ctrl.)--treated *Tcrd*-GDL mice 4 wk after γδ T cell depletion. Representative fluorescence microscopy images out of two independent experiments with *n* = 1--2 mice each; blue: Vγ5; red: CD3; white: DAPI nuclear staining. Bars, 50 µm. **(D)** Epidermal sheets of hetero- and homozygous *Tcrd*-GDL mice were stained with anti-CD3ε (red) 18 d after depletion (DTx) or PBS injection (ctrl.). Bars, 100 µm. Staining was validated in three experiments with *n* = 1--2 mice each.](JEM_20181439_Fig3){#fig3}

To complement our results on the differential regeneration of Tγδ17 and other γδ T cell subsets with a fate mapping system, we next used an inducible γδ T cell--specific Cre system to track their relative persistence in vivo. Tamoxifen-induced Cre activation in *Tcrd*^CreER^ × R26^tdRFP^ mice ([@bib82]) led to permanent RFP gene expression in 33% of all γδ T cells in pLN and spleen and 20% in liver after 2 wk ([Fig. 4, A and B](#fig4){ref-type="fig"}). 7 wk after tamoxifen gavage, most CD27^+^CD44^low^ γδ T cells with an IFN-γ--producing phenotype had lost their RFP label, suggesting that this subset is constantly replenished by newly generated γδ T cells from the thymus ([Fig. 4 C](#fig4){ref-type="fig"}). At the same time, the frequency of RFP-labeled cells among CD27^--^CD44^high^ Tγδ17 cells was highly persistent in pLN, spleen, and liver after 7 wk ([Fig. 4 C](#fig4){ref-type="fig"}). In the skin of *Tcrd*^CreER^ × R26^tdRFP^ mice, genetic labeling of both epidermal and dermal γδ T cells was remarkably efficient ([Fig. 4 D](#fig4){ref-type="fig"}). However, the frequency of dermal RFP^+^ γδ T cells but not of epidermal RFP^+^ DETCs decreased after 7 wk, indicating a higher turnover of Tγδ17 cells infiltrating the dermis as compared with Tγδ17 cells in pLN. It is thus conceivable that dermal Tγδ17 cells may also exchange with distant tissues including lymph nodes ([@bib21]; [@bib60]), in line with the idea that effector γδ T cells with a Tγδ17 phenotype can be selectively trapped in lymph nodes ([@bib7]; [@bib67]; [@bib2]; [@bib73]).

![**Tγδ17 cells are long lived and self-renewing. (A)** Inducible γδ T cell fate-mapping model. RFP expression in γδ T cells was induced by oral administration of tamoxifen (left). Representative gating for RFP^+^ peripheral lymph node γδ T cells 7 wk after tamoxifen administration (right). **(B and C)** Analysis of RFP^+^ cells from indicated tissues and time points after RFP induction. One dot equals one mouse, pooled data from three independent experiments with each three to six littermate mice per time point, mean. **(B)** Frequencies of RFP^+^ γδ T cells. **(C)** Frequencies of RFP^+^ cells among IFN-γ (left) or IL-17 (right) phenotype γδ T cell subsets, defined as CD3^+^Tcrβ^--^γδTCR^+^CD44^hi^CD27^--^ and CD3^+^Tcrβ^--^γδTCR^+^CD44^--^CD27^+^, respectively. **(D)** Mean frequency of RFP^+^ cells among skin-derived γδTCR^hi^ DETCs and γδTCR^lo^ dermal γδ T cells. One dot equals one mouse, pooled data from two experiments with each three to five littermate mice per time point, mean.](JEM_20181439_Fig4){#fig4}

Next, we investigated the impact of γδ T cell depletion in *Tcrd*-GDL mice in imiquimod (IMQ)--induced skin pathology ([@bib75]; [@bib5]; [@bib50]). We hypothesized that Tγδ17 cells should play crucial and nonredundant roles in this experimental model for human psoriasis, because the importance of Tγδ17 cells inducing psoriasis pathology was suggested before in this IMQ model ([@bib5]; [@bib50]), as well as in a related model for psoriasis based on intradermal IL-23 injection ([@bib39], [@bib40]) and in the human system ([@bib36]). However, constitutively γδ T cell--deficient *Tcrd*^−/−^ mice showed similar neutrophil influx ([Fig. 5 A](#fig5){ref-type="fig"}), disease scores, and epidermal thickening as compared with γδ T cell--sufficient mice after IMQ treatment ([Fig. 5, B and C](#fig5){ref-type="fig"}). In contrast, these disease parameters were significantly reduced in acutely depleted *Tcrd*-GDL mice ([Fig. 5, A--C](#fig5){ref-type="fig"}), likely because the absence of pathogenic Tγδ17 cells led to an overall decrease of IL-17--producing dermal lymphocytes ([Fig. 5 D](#fig5){ref-type="fig"}). Thus, acute depletion of γδ T cells in *Tcrd*-GDL mice, but not constitutive absence of γδ T cells in *Tcrd*^−/−^ mice, conferred a strong protection against psoriasis pathology. Additionally, direct visualization of motile dermal γδ T cells that migrated across the basement membrane straight into the inflamed epidermis of IMQ-treated skin further supported a direct and tissue-confined contribution of γδ T cells to epidermal inflammation in IMQ-induced psoriasis ([Fig. 6, A--C](#fig6){ref-type="fig"}; and Video 4). However, analysis of the track straightness and mean track speed of the motile γδ T cells entering the inflamed epidermal layers was not altered, refuting the hypothesis that their movement was driven by antigen-specific cell-to-cell interactions with epidermal cells ([Fig. 6 B](#fig6){ref-type="fig"}).

![**Freshly γδ T cell-depleted mice develop less severe IMQ-induced psoriasis. (A--C)** IMQ-induced psoriasis. Ears of indicated genotypes were treated with IMQ or Vaseline (Vas.), starting at day 3 after γδ T cell depletion (DTx). **(A)** Ear skin immunofluorescence histology at day 8 of IMQ treatment of mice shown in B, CD3^+^ T cells (blue), and CD11b^+^Ly6G^+^ neutrophils (yellow). Bars, 100 µm. Representative images from of two independent experiments with *n* = 1--4 mice each. **(B)** Change of ear thickness given as percent diameter of untreated ears (day 0; left) and disease score (right) over time. Graphs show pooled data from three experiments, each one to four mice per group (total numbers of mice: seven *Tcrd*-GDL DTx IMQ; eight *Tcrd*-GDL ctrl. IMQ; seven *Tcrd*^−/−^ IMQ; six *Tcrd*-GDL DTx Vas; five *Tcrd*-GDL ctrl. Vas; six *Tcrd*^−/−^ Vas); two-way ANOVA with Bonferroni posttests, mean ± SD. **(C)** Epidermal hyperplasia measured on H&E-stained ear skin sections of IMQ- and Vaseline-treated ears of the indicated genotypes, respectively. Scatter plot shows quantification of the epidermal thickening measured on the sections; each dot represents one measurement acquired on 36 slides of two mice per group (left). Representative images out of two mice per group. Bars, 50 µm (right). Data were validated in two independent experiments. **(D)** Steady state mean frequency of IL-17A--producing CD45^+^ lymphocytes in ear skin of control (ctrl.) and γδ T cell--depleted *Tcrd*-GDL mice, day 3 (d3) after depletion, compared with *Tcrd*^−/−^ mice by intracellular flow cytometry. Pooled data from three to five experiments with each *n* = 2--4 mice per group; one dot equals one mouse, mean. One-way ANOVA with Bonferroni posttests. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant.](JEM_20181439_Fig5){#fig5}

![**Dermal γδ T cells translocate into epidermis under inflammatory conditions. (A and B)** In vivo two-photon imaging of *Tcrd*-GDL Vaseline- (ctrl.) and IMQ-treated ear skin, respectively. Shown are pooled data from three experiments with each one to two mice per group, Student's *t* test. **(A)** Using IMARIS software motile dermal γδ T cells (red dots) were tracked and dermis was defined as surface by second harmonics signal corresponding to collagen (blue, right). Frequency of motile γδ T cells in epidermis (see Video 4), one dot per video (left). **(B)** Scatter plots show track straightness (displacement length divided by track length, left) and mean track speed (right). **(C)** Ear skin histology of inflamed *Tcrd*-H2BeGFP ears (representative image of two different stainings). Mice were treated for five consecutive days with Vaseline (ctrl.) or IMQ-containing cream (Aldara; IMQ). Red: epidermis (keratin 14); green: GFP^+^ γδ T cells below epidermis; purple: GFP^+^ Vγ5^+^ dendritic epidermal T cells (blue Vγ5^+^ cells); yellow: GFP^+^Vγ5^--^ dermal γδ T cells within epidermis. Bars, 50 µm. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant.](JEM_20181439_Fig6){#fig6}

Next, we investigated the regeneration of dermal IL-17 immunity after conditional depletion of γδ T cells. Despite the sustained lack of Tγδ17 cells in the dermis of DTx-treated *Tcrd*-GDL mice ([Fig. 3 A](#fig3){ref-type="fig"}), overall frequencies of IL-17--producing dermal CD45^+^ lymphocytes rebounded to pretreatment levels within 2 mo, in part through expansion of a few surviving Tγδ17 cells, but mainly due to an increased abundance of TCR^--^Thy1^+^ ILC3s ([Fig. 7 A](#fig7){ref-type="fig"}). While Tγδ17 cells are the major population of IL23R^+^ lymphocytes in the skin, [Fig. 7 B](#fig7){ref-type="fig"} shows that also some dermal ILCs and Th17 cells are expressing the IL-23R in steady state, and it is thus tempting to speculate that these are the cells that expand via elevated availability of homeostatic cytokines such as IL-23 in the absence of Tγδ17 cells. Accordingly, previously depleted *Tcrd*-GDL mice regained susceptibility to IMQ-induced pathology ([Fig. 7 C](#fig7){ref-type="fig"}). Of note, the experiments shown in [Fig. 7 C](#fig7){ref-type="fig"} suggested that ear thickening in previously depleted and recovered *Tcrd*-GDL mice might still be less pronounced than in undepleted *Tcrd*-GDL mice or in *Tcrd*^−/−^ mice, but the differences were marginal and based on statistical outliers. At 9 wk after depletion and induction of psoriasis, IL-17 in cervical lymph nodes, including ear skin draining lymph nodes, was mainly produced by Th17 αβ T cells and lineage-negative ILC3s (Th17, 33.15 ± 3.15%; ILC, 48.97 ± 6.37%; [Fig. 7 D](#fig7){ref-type="fig"}). This is in agreement with the hypothesis that pathogenic ILC3s in the skin of constitutively γδ T cell--deficient *Tcrd*^−/−^ mice can compensate for the lack of γδ T cells ([@bib50]; [@bib15]). After depletion of Tγδ17 cells in adult *Tcrd*-GDL mice, compensating ILC3s might have been recruited from the circulation; however, their established strict tissue-residency would advocate for local homeostatic expansion ([@bib14]). Nevertheless, the observed loss of protection at 9 wk after γδ T cell depletion could also be compensated in part due to the reappearance of Tγδ17 cells in skin and pLN. To test this, we performed a second round of DTx treatment at 9 wk after a first ablation of γδ T cells ([Fig. 8 A](#fig8){ref-type="fig"}). This additional depletion regimen could efficiently reablate γδ T cells including the few recovered Tγδ17 cells ([Fig. 8 B](#fig8){ref-type="fig"}), and as a consequence, the severity of IMQ-induced psoriasis as measured by ear thickening and disease score were again diminished after a second γδ T cell depletion ([Fig. 8 C](#fig8){ref-type="fig"}). Together, these data strongly suggest a nonredundant contribution of γδ T cells to epidermal inflammation in IMQ-induced psoriasis. Such an essential role of Tγδ17 cells for psoriasis pathology was somehow expected from previous observations in WT mice, but so far, experimental evidence was cloaked by compensatory expansion of other IL-17--producing lymphocytes in constitutively γδ T cell--deficient *Tcrd*^−/−^ mice and became only clear after conditional ablation of γδ T cells in immunocompetent mice.

![**αβ T cells and ILCs can compensate absent Tγδ17 cells. (A)** Frequencies of indicated cell populations among IL-17A^+^ cells. *Tcrd*-GDL ctrl.: nondepleted; *Tcrd*-GDL 8w: 8 wk after γδ T cell depletion. Shown are pooled data from two experiments with each *n* = 2--4 mice per group, mean ± SD. **(B)** Frequencies of indicated cell populations among IL23R-GFP^+^ ear skin lymphocytes from heterozygous IL23R-GFP reporter mice. Pooled data from two experiments with each *n* = 2--3 mice per group, mean. **(C)** Ear thickness and disease score over time in control and IMQ-treated groups. IMQ treatment started 9 wk after γδ T cell depletion. Graphs show pooled data from two experiments, each *n* = 1--3 mice per group (total numbers of mice: five *Tcrd*-GDL DTx IMQ; six *Tcrd*-GDL ctrl. IMQ; six *Tcrd*^−/−^ IMQ; two *Tcrd*-GDL DTx Vas; three *Tcrd*-GDL ctrl. Vas; three *Tcrd*^−/−^ Vas); two-way ANOVA with Bonferroni posttests, mean ± SD. **(D)** Composition of IL-17A--producing lymphocytes from psoriatic ear skin draining lymph nodes day 8 of IMQ-psoriasis, 9 wk after γδ T cell depletion. Frequencies of indicated cell populations in nondepleted *Tcrd*-GDL control (ctrl.) compared with *Tcrd*-GDL mice that were treated with DTx 9 wk before psoriasis induction (DTx 9 w). Data shown are from one representative experiment out of two independent experiments with each *n* = 2--3 mice per group. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant.](JEM_20181439_Fig7){#fig7}

![**Redepletion of γδ T cells confers reprotection in IMQ-induced psoriasis. (A)** For redepletion of γδ T cells, mice were treated twice with DTx at 9 wk and 3 d, before IMQ treatment. Mice of the recovered group were treated only once with DTx at 9 wk before IMQ treatment. **(B)** Littermates of *Tcrd*-GDL mice were treated as described in A. Mean frequency of cervical LN (cLN) γδ T cells of d8 IMQ-treated *Tcrd*-GDL mice. One dot represents one mouse; one experiment representative of two is shown. **(C)** Ear thickness over time of indicated groups. IMQ treatment started 9 wk after first γδ T cell depletion. Shown are pooled data from two independent experiments with each two to four mice per group, mean ± SD. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, not significant.](JEM_20181439_Fig8){#fig8}

Discussion {#s03}
==========

This work used γδ T cell--specific genetic systems to demonstrate that Tγδ17 cells play nonredundant roles in IMQ-induced skin inflammation and clarified that they are poorly generated de novo in adult mice. Namely, we used tamoxifen-induced Cre activation in *Tcrd*^CreER^ × R26^tdRFP^ mice ([@bib82]) to track the persistence of Tγδ17 cells, and we established *Tcrd*-GDL mice for conditional depletion of γδ T cells mice that displayed an otherwise normal WT γδ T cell compartment. We expect that the *Tcrd*-GDL system will be instructive for delineating the physiological role of γδ T cells in a plethora of further experimental models for human disease.

Technically, injection of a relatively small dose of DTx was sufficient for depleting \>96% of all γδ T cells. Of note, this procedure did not facilitate opportunistic infections, at least under specific pathogen--free conditions, nor did the treated mice suffer from intolerable barrier defects. Therefore, the system can be applied to investigate specific functions of γδ T cells in vivo. Furthermore, multiple rounds of quantitative γδ T cell depletion are possible because the DTR gene in the *Tcrd*-GDL strain is a knock-in to the 3′-UTR of the functional endogenous *Tcrd* constant gene and thus, depletion does not foster the outgrowth of DTR-negative γδ T cells as observed in BAC-transgenic systems ([@bib37]). While peripheral αβ T cell populations were not significantly affected by DTx treatment of *Tcrd*-GDL mice, a limitation of the system is the observed collateral transient depletion of developing CD4/CD8 double-negative and double-positive αβ T cell precursors. This precludes using the model for direct assessment of γδ T cell functions within the thymus. On the other hand, this feature might serve to further revisit the kinetics of thymic αβ T cell development ([@bib43]; [@bib13]).

Next to genetic ablation by immune cell--specific DTR expression ([@bib77]; [@bib37]; [@bib74]), monoclonal antibody (mAb)--mediated depletion via complement lysis is frequently used in loss-of-function studies without the need for breeding mutant mice. For example, NK cells in NK1.1-bearing mouse strains can be efficiently depleted by injection of the PK136 mAb ([@bib34]). However, in vivo ablation of γδ T cells using any currently available mAb does not work. As it had been suspected already for a long time ([@bib30]; [@bib31]), *Tcrd*-H2BeGFP reporter mice could prove that injection of mAbs directed against the γδ TCR, such as clones UC7-13D5 ([@bib22]) or GL3 ([@bib16]), does not deplete γδ T cells, but leads to TCR internalization and thereby generates "invisible" γδ T cells ([@bib32]). Still, several studies found opposing effects of γδ T-cell depletion and adoptive transfer of γδ T cells, as well as similar experimental outcomes in *Tcrd*^−/−^ and anti-γδ TCR-treated mice. Therefore, mAb-mediated in vivo blocking of the γδ TCR could be seen as a "functional depletion" and as such is certainly useful to investigate the specific role of the γδ TCR in immune responses of γδ T cells, for example in response to malaria infection ([@bib41]). Of note, the low efficiency of the γδ T cell--specific Cre system in *Tcrd*^CreER^ mice ([@bib82]) precludes quantitative depletion of γδ T cells in ROSA-DTA mice ([@bib76]).

Functionally, acute depletion of γδ T cells showed a different phenotype in IMQ-induced psoriasis as compared with constitutively deficient *Tcrd*^−/−^ mice ([@bib25]), i.e., protection versus susceptibility, respectively. This underlines previous findings that αβ T cells can invade the niches of absent γδ T cells and might partially take over their functions ([@bib26]). While compensatory αβ DETCs were not able to properly respond to keratinocyte damage like genuine γδ DETCs ([@bib26]), we show here that dermal ILC3 and Th17 cells were sufficient to induce psoriasis pathology in the absence of γδ T cells. An alternative explanation for protection of acutely depleted *Tcrd*-GDL mice from IMQ-induced psoriasis would be a strong imbalance of quickly regenerated of Vγ1 T cells and poorly regenerated IL-17--producing Vγ4 and Vγ6 γδ T cells, which may subsequently alter the balance of other adaptive immune cells including αβ T cells and B cells ([@bib23], [@bib24]). However, this interpretation is flawed by the finding that this imbalanced ratio of overrepresented Vγ1 versus underrepresented (IL-17--producing) Vγ4/6 γδ T cells was still observed after 7 wk, a time point at which the previously depleted mice were no longer resistant to IMQ-induced psoriasis.

In any case, our observations may seem to be contrasting previous results that found significantly decreased IMQ-induced skin pathology in *Tcrd*^−/−^ mice ([@bib5]; [@bib50]). However, experimental details such as the investigation of either IMQ-treated ear skin or back skin, along with the precise genetic background of the mice, and different microbiota might strongly bias the outcome of such experiments. Most importantly, skin microbiota can autonomously control the local inflammatory milieu and tune resident Th17 and CD8^+^ T cell function ([@bib49]; [@bib47]). Even so, our study further underlines that Tγδ17 cells are the major population of IL23R^+^ lymphocytes in the skin and the main source of IL-17 in IMQ-induced inflammatory pathology in immunocompetent mice. The fact that this function can be compensated by other IL-17--producing lymphocytes in *Tcrd*^−/−^ or Rag^−/−^ mice highlights the biological importance of the IL-23--IL-17 cytokine axis for skin homeostasis and antimicrobial immunity ([@bib15]; [@bib10]). Also, in contrast to the mouse model, recent investigations of human psoriasis suggested that Tγδ17 cells are rare in human psoriatic skin and rather outnumbered by Th17 cells with an innately biased TCR repertoire ([@bib42]; [@bib44]). Furthermore, CD8^+^ T cells have been implicated in the pathogenesis of human psoriasis ([@bib20]; [@bib12]). A recent study showed that the CD8^+^ T cell response in psoriasiform inflammation is controlled by regulatory T cells, as their depletion led to CD8^+^ T cell expansion and exacerbated skin inflammation ([@bib69]). At the same time, dermal γδ T cell expansion was not observed in regulatory T cell--depleted mice ([@bib69]). This indicated that the IMQ-induced pathology after regulatory T cell depletion is driven by alternative pathways, possibly more resembling to human psoriasis pathology.

In future studies, the combination of *Tcrd*-GDL mice, *Tcrd*^−/−^ mice, and γδ TCR blocking with mAbs will make a powerful triad of three independent loss-of-γδ T cell--function strategies. Comparing their different phenotypes should be very helpful to elucidate the in vivo functions of γδ T cells in models for human disease including infections, autoimmunity, and cancer.

Materials and methods {#s04}
=====================

Animals {#s05}
-------

*Tcrd*-GDL, *Tcrd*^−/−^ (B6.129P2-Tcrdtm1Mom/J; [@bib25]), *Tcrd*CreERSxRosa26-StopRFP mice, obtained by crossing *Tcrd*CreERS ([@bib82]) to *Rosa26*tdRFP mice ([@bib38]), heterozygous C57BL/6-Il23r^tm1Kuch^ (here IL23-R-eGFP) mice ([@bib3]), and *Tcrd-*H2BeGFP ([@bib57]) mice were bred and housed under specific pathogen--free conditions in the central animal facility at Hannover Medical School. C57BL/6-NCrl (WT) mice were purchased from Charles River Laboratories. Unless specified otherwise, mice were analyzed at 7--20 wk of age. All experiments were conducted according to local and institutional guidelines. The study was approved by the Lower Saxony State Office for Consumer Protection and Food Safety, file reference 33.12-42502-04-15/1889.

Generation of *Tcrd*-GDL mice {#s06}
-----------------------------

We inserted an expression cassette encoding eGFP, human DTR and luciferase (Luc; [@bib70]) into a modification of the vector used to generate *Tcrd-*H2BeGFP mice ([@bib57]). Electroporation and homologous recombination to the 3′UTR of the *Tcrd* constant gene in JM8A3 ES cells was screened by PCR and by Southern blot. Selected ES cell clones were expanded and subsequently injected into blastocysts to generate knock-in mice on the C57BL/6 genetic background (*Tcrd*-GDL mice). Chimerism in F0 offspring was identified by fur color, positive F0 offspring were mated with C57BL/6N mice, and F1 offspring were tested for germline transmission and successful excision of the Neo cassette by PCR (PCR primers: GDLδ forward: 5′-CTAGAAGAAAAGCAAAAGCCCTC-3′; GDL-IRES reverse: 5′-AAACGCACACCGGCCTTATT-3′; GDLδ reverse: 5′-CCTTCCTTTCGGTATTTTACTTTCA-3′; knock-in fragment size: 412-bp; WT fragment size: 519 bp).

γδ T cell depletion {#s07}
-------------------

For conditional depletion of γδ T cells mice were treated with 30 ng DTx per gram body weight by i.p. injection. The optimal regimen for quantitative γδ T cell depletion was titrated as two injections of 15 µg DTx per gram body weight separated by 48 h. This DTx treatment regimen did not affect lymphocytes in WT mice in control experiments. *Tcrd*-GDL mice in control groups were injected with PBS (*Tcrd*-GDL ctrl.). In experiments comparing *Tcrd*-GDL control and DTx treated mice, we used littermates.

*Tcrd*-Cre induction *Tcrd*CreER × R26tdRFP mice were gavaged with 4 mg tamoxifen citrate (Enzo Life Sciences), dissolved in 400 µl corn oil/ethanol, three times every other day to induce Cre expression and subsequently RFP expression by γδ T cells.

In vivo imaging system (IVIS) {#s08}
-----------------------------

IVIS 200 system (PerkinElmer) and Living Image software 2.50.2 (Caliper LifeScience) was used for detection of bioluminescence. For images shown, mice were sacrificed 10 min after i.p. injection of 400 µg [d]{.smallcaps}-luciferin.

IMQ-induced psoriasis {#s09}
---------------------

To induce psoriasis, both ears were treated daily with 5 mg Aldara cream (5% IMQ) per ear for seven consecutive days. Ear thickness was measured starting 2 d before the first treatment (day 0) and set to 100%. Ear thickness was measured using a caliper. Reddening and scaling were evaluated daily and scored with 0: no change, 1: mild, 2: moderate, and 3: severe. Reddening and scaling were assessed separately to calculate an average cumulative disease score. For treatment, mice were anesthetized with Ketamin/Rompun and supplemented i.p. with 0.9% NaCl to avoid dehydration.

Preparation and staining of epidermal sheets {#s10}
--------------------------------------------

Fur was carefully removed from mouse ears using a scalpel and dorsal and ventral parts were separated. Subsequently, with dermal side down, they were incubated on 0.5 M NH4SCN at 37°C for 20 min. Afterward, epidermis was peeled off and fixed using 4% paraformaldehyde at room temperature for 15 min. Before antibody staining epidermal layers were rehydrated in PBS for 20 min at room temperature and blocked with 8% rat serum. Sheets were stained with the indicated antibodies for 2 h at room temperature and analyzed with an Olympus BX641 microscope. Antibodies directed against TCRβ (clone H57-597; Alexa Fluor 488) and Vγ5 (clone 536; APC) were purchased from BioLegend. Anti-CD3 (clone 17A2) was produced from a rat hybridoma cell line and subsequently labeled with Cy5 or Cy3.

Skin histology {#s11}
--------------

Ear skin was frozen in Tissue Tek optimal cutting temperature compound (Sakura Finetek) and 8-µm cryosections were cut using a cryo microtome (CM3050; Leica). Cryosections were fixed for 10 min with ice-cold acetone and stored at −20°C or used directly for staining. Slides were either stained with H&E or for immunofluorescent microscopy with the indicated antibodies. All samples were covered with Mowiol and examined with an Olympus BX641 fluorescence microscope using CellSense Dimension software (Olympus). Following antibodies were used: anti-CD3 clone 17A2 (Cy5; rat hybridoma cell line), anti-Ly6G clone 1A8 (PE; BioLegend), anti-CD11b clone MAC-1 (FITC; rat hybridoma cell line), anti-cytokeratin K14 clone Poly19053 (unlabeled; BioLegend), and anti-rabbit polyclonal (Cy3, Dianova) to detect the K14 antibody.

Flow cytometry {#s12}
--------------

Single-cell suspension from peripheral lymph nodes, spleen and liver were prepared by meshing the organs through nylon gaze or 100 µm nylon cell strainers (Falcon), respectively. Subsequently, liver lymphocytes were purified by density gradient centrifugation using Percoll gradients. For the preparation of ear skin lymphocytes, four separated halves of one ear pair were digested with collagenase IV (2 mg/ml; Worthington) and DNase I (187.5 µg/ml) for 1 h 30 min at 37°C. For the last 15 min of incubation EDTA (final concentration, 37.5 mM) was added. Subsequently, remaining tissue was dissociated mechanically facilitating a 1--2-cm long 19-G syringe needle and filtered through 50 µm CellTrics (Sysmex). Afterward, lymphocytes were isolated by density gradient centrifugation using Percoll gradients.

Before antibody staining, Fc-receptors were blocked with FcR antibody (clone 2.4G2) on ice for 5 min. For intracellular staining, BD Biosciences Cytofix/Cytoperm Fixation/Permeabilization kit was used according to the manufacturer's instructions. Live/dead discrimination in intracellular cytokine staining protocols was performed using Zombi Aqua Fixable Viability kit (BioLegend; A.dead) according to manufactures instructions. Antibodies directed against CD3 (clone 17A2; APCVio770), TCRβ (clone REA318; APCVio770), CD45.2 (clone 104-2; PerCPVio700 or VioGreen), and CD44 (clone IM7.8.1; VioBlue) were purchased from Miltenyi Biotec. Antibodies directed against CD3 (clone 145-2C11; PECy7) and IL-17A (clone eBio17B7; Alexa647) were from eBioscience. The following antibodies were produced from rat hybridoma cell lines and subsequently labeled with the indicated fluorochromes: anti-CD3 clone 17A2 (Cy5), anti-CD4 clone RMCD4-2 (Cy 5), anti-CD8β clone RMCD8-2 (Pacific Orange), anti-TCRγδ clone GL3 (Alexa488), and anti-Vγ4 clone 49.2 (subclone 49.2-9, Cy5). Antibodies directed against Vγ5 (clone 536, APC), CD27 (clone LG.7F9, PerCPCy5.5), Vγ1 (clone 2.11, PE), NK1.1 (clone PK136, PECy7), IL-17A (clone TC1118H10.1, PE), and CD19 (clone 6D5, PECy7) were purchased from BioLegend. Staining of Vγ6 was performed as described previously ([@bib65]). In short, the IgM anti-Vγ5 clone 17D1 binds additionally to TCRs using the Vγ6 chain after preincubation of cells with anti-TCRγδ (clone GL3). Subsequently, 17D1 was detected with anti-IgM PE (clone RM-7B4; eBioscience).

Two-photon laser-scanning in vivo imaging {#s13}
-----------------------------------------

An upright Leica DM LFSA microscope equipped with a 20 × 0.95 numerical aperture water immersion objective (Olympus) and a pulsed Ti:Sa infrared laser (MaiTai, Spectra Physics) turned to 920 nm was used for two-photon laser-scanning microscopy. During image acquisition, ears were fixed with a coverslip on a custom build metal plate heated to 37°C. For detection of eGFP nondescanned, detectors fitted with 525/50 band path filter were facilitated; for detection of second harmonics and Hoechst 33342, 447/60 band path filters were used. Hoechst 33342 was used to visualize nuclei during small intestine in vivo imaging. During ear skin imaging the second harmonics signal was used to identify collagen-rich tissues like the dermis. Longitudinal imaging of skin γδ T cell recovery was applied to the same mice at indicated time points after γδ T cell depletion. Control mice were injected with PBS (control).

For localization of motile γδ T cells in inflamed skin, ears of *Tcrd*-GDL or *Tcrd-*H2BeGFP mice were treated for four to seven consecutive days with Vaseline (control) or IMQ Using IMARIS 7.6.4 software (Bitplane); motile GFP^+^ γδ T cells were defined with red dots and tracked. The surface of dermis was visualized by surface rendering of the second harmonics signal of the collagen localized in the dermis.

High-throughput TCR sequencing {#s14}
------------------------------

For mRNA-based TCR analysis, paired-end Illumina sequencing was performed as described ([@bib62]). In brief, for mRNA isolation sorted CD44^high^Ly6C^--^Vγ4^+^ peripheral lymph node cells were pooled from seven to eight *Tcrd*-GDL control-- and DTx-treated mice each (RNase mini kit; Qiagen). Subsequently, mRNA was reverse transcribed into cDNA (superscript III; Invitrogen). CDR3 regions of *Tcrg* and *Tcrd* were PCR-amplified using Taq polymerase (Invitrogen) and gene-specific primers targeting TCR variable (V)- and constant (C)-regions with Illumina sequencing adapter sequences as overhangs (5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG and TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3′). Gene-specific primer sequences were for TrgV4: 5′-TCCTTGGAGGAAGAAGACGA-3′; TrgC: 5′-CTTATGGAGATTTGTTTCAGCA-3′; TrdV5: 5′-TAGGGACGACACTAGTTCCCATGAT-3′; TrdC: 5′-ATGATGAAAACAGATGGTTTGG-3′. Each PCR reaction contained 5--7.5 µl cDNA as template in a final volume of 20 µl. PCR products were size selected on 1% agarose gels and purified with Qiagen gel extraction kits. For paired-end 500-cycle Illumina Mi-Seq analysis, amplicons were coded with Nextera Index primers. Sequencing libraries were calibrated to 4 nM and processed according to the Illumina "denature and dilution guide." 20% PhIX was added to control sequencing performance and for warranting library diversity. Generated Fastq files were annotated according to IMGT/High-Vquest ([@bib1]). For downstream analysis, only productive sequences with unambiguous V-gene segment were considered. *Tcrg* and *Tcrd* clonotypes were identified based on identical CDR3 region sequences. Results are presented as percentages of all productive reads per sample to normalize between samples. All R and bash shell scripts were based on previous analysis strategies ([@bib62]). TCR sequences are published under SRA number [SRP130082](SRP130082).

Statistical analyses {#s15}
--------------------

All statistical analyses were performed using GraphPad Prism software (Version 4.03). Differences between individual groups were analyzed for statistical significance as indicated in legends using either unpaired Student's *t* test, one-way, or two-way ANOVA followed by Dunn's Multiple Comparison or Bonferroni posttests. P values \< 0.05 were considered as significant different (\*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001).

Online supplemental material {#s16}
----------------------------

Fig. S1 illustrates the strategy used to generate *Tcrd*-GDL mice. Fig. S2 shows further characterization of *Tcrd*-GDL mice including depletion efficiency. Fig. S3 shows differential recovery of γδ T cell populations after depletion. Fig. S4 focuses on the empty DETC niche after depletion. Further supplemental material includes four in vivo two-photon imaging videos. Videos 1 and 2 show γδ T cell motility in ear skin and small intestine, respectively. Video 3 shows recovery of skin γδ T cells over time. Video 4 compares γδ T cells in healthy and psoriatic inflamed ear skin.

Supplementary Material
======================

###### Supplemental Materials (PDF)

###### Video 1

###### Video 2

###### Video 3

###### Video 4
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